TrialThe oncologist2025

Intergroup randomized phase III study of adjuvant FOLFIRI, FOLFOX, or 5-FU/leucovorin for stage II/III rectal cancer: ECOG-ACRIN E3201.

Audrey E Kam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.